SMYD3 and neoplasm: Because elevated Smyd3-Shcbp1 signaling increases the PD1 and CD8 double-positive cell population (Fig. 6n), we next explored single and double treatment with Tra and αPD1 in tumor-bearing FVB mice, which have an intact immune system, with implantation of HP5712 cells.